AFJK Company Profile and Key Details

Aimei Health Technology Co., Ltd has 6.12 million shares outstanding. The public float is 4.40 million shares, elevated short interest at 0.13% of float. This equals 3.57 thousand shares. The short ratio is 0.48 days. Institutional investors hold 90.66% of the float. Insiders own 33.6%.

Short-term trend indicators are mixed aligned (SMA20 -27.91%, SMA50 -36.0%, SMA200 49.73%). The stock’s 14-day RSI is 34.06 (weak momentum), while the ATR of 6.93 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -75.22% below its high and over 378.67% above its low. Average 10-day trading volume of 108.96 thousand shares is significantly above the 3-month average of 22.46 thousand, indicating heightened recent market interest.

Aimei Health Technology Co., Ltd last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.02. This means the shares are trading below this model’s fair value.

Aimei Health Technology Co., Ltd (NASDAQ:AFJK) closed at $48.26 USD, losing -$2.94 (-5.74%) from the previous close of $51.20. The stock is currently mid-range between its 52-week high and low $6.75 and $130.37. With a market capitalization of about $295.43 million, Aimei Health Technology Co., Ltd is classified as a micro-cap and shows lower-than-market volatility (beta ~-1.50). Key stats such as the average daily volume over the past year has been around 20.65 thousand shares, volume is running light vs its 52-week average. Headquartered in New York City, NY, Aimei Health Technology Co., Ltd operates in the Financial Services sector and the Shell Companies industry. Led by CEO Junheng Xie, the company employs approximately 2 people and listed since January 22, 2024. Aimei Health Technology Co., Ltd does not have significant operations.

Aimei Health Technology Co., Ltd (NASDAQ:AFJK) shares are down -26.86% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Aimei Health Technology Co., Ltd trading at a premium to the broader market with a P/E of 146.38. Our AI forecast model points to short-term weakness (-8.46% over two weeks), a medium-term rise (48.44% over three months), and a longer-term gain (18.86% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Aimei Health Technology Co., Ltd stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -8.46%, with price expected at $47.42 by April 28, 2026, within a range of $36.76 to $57.57 3-Month Outlook: Projected rise of 48.44%, reaching $76.89 by July 13, 2026, with a range of $74.55 to $79.40. 1-Year Outlook: Projected gain of 18.86%, with price at $61.57 by April 14, 2027, within a range of $57.68 to $66.20.

Aimei Health Technology Co., Ltd trades at a P/E ratio of 146.38, slightly above the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 4.9 trading at moderately above to book value. The P/FCF stands at -439.71, also above market averages.